Bluejay Therapeutics, Inc.
ID: 7646713Bluejay Therapeutics, Inc. is a monoclonal Antibody, Small Molecule founded in 2019.
2
Funding Rounds
$65.4m
Money raised
Recent Funding Rounds
Overview
Bluejay Therapeutics, Inc. is a monoclonal Antibody, Small Molecule founded in 2019.
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Na*** A Ho** | - | - | linkedin twitter |
Funding series
Funding Series Analysis
The company Bluejay Therapeutics, Inc. has raised a total of $41.15m in funding over 2 rounds.
Key Insights:
- Bluejay Therapeutics, Inc. Funding Round, August 2022: $41.15m
- Bluejay Therapeutics, Inc. funding round, June 2021: $24.24m